NZ probes reformulated GSK med; Protestors assault NICE over cancer drugs;

> More than 500 New Zealanders have complained of side effects from the reformulation of a GlaxoSmithKline thyroid drug, Eltroxin, prompting an investigation by drug regulator Medsafe. Report

> Cancer patients briefly occupied the headquarters of the UK's National Institute for Health and Clinical Excellence, protesting the regulatory body's decision to deny payment for costly kidney cancer drugs. Report

> India's Marksans Pharma today said it has acquired UK-based generic pharmaceutical company Relonchem for an undisclosed amount. Report

> Researchers found that when physicians gave an infusion of magnesium sulfate to women at imminent risk for preterm delivery--between 24 and 31 weeks of gestation--the odds of their infants later developing cerebral palsy dropped by almost half. Report

> The blood pressure drug telmisartan, sold by Boehringer Ingelheim under the brand name Micardis, does not lower the rate of stroke, cardiovascular events or diabetes better than a placebo in patients who have had a stroke, a new study finds. Report

> A&D Pharma Holdings said chief executive Dragos Dinu and chief financial officer Roger de Bazelaire are stepping down. Report

> A closely-watched trial for Cell Genesys' prostate cancer vaccine GVAX was brought to a sudden halt after an independent monitoring committee noted a significantly higher death rate in the group taking a combination of the vaccine and Taxotere compared to the control arm of the study. Report

> Pain Therapeutics and King Pharmaceuticals, which are already partnered in a major pain drug program, say they are developing a new abuse-resistant prescription pain medication called PTI-721. Report

> Shares of Sangamo BioSciences were buoyed by positive preliminary data from a small mid-stage study of SB-509. Report

> Researchers at the University of Kentucky are involved in a new study of an experimental smallpox vaccine being developed by Bavarian Nordic. Report

> VaxInnate's universal flu vaccine has produced positive results in an early stage trial at the University of Texas at Galveston. Report

And Finally... In any given week, 10 million Americans are taking opioid meds, and more than 4 million are taking them regularly. Report

Suggested Articles

It's taken years for Amarin's Vascepa to prove itself as a game-changing treatment for CV disease. An FDA committee may have just punched its pass.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

With a potential approval next year in the up-and-coming NASH field, Intercept is staffing up its sales team and starting talks with payers.